Bristol-Myers Squibb divested the Questran range to Cheplapharm at the end of July 2019. This affected the availability of several bile acid sequestrants. The current stock situation is as follows:
- Questran (Cheplapharm) – out of stock; resupply expected third quarter 2021Questran Light (Cheplapharm) – in stock
Colestyramine light 4g sachets – Mylan – in stock
Cholestagel (colesevelam) 625mg tablets (Sanofi) – in stock
Colestid (colestipol) plain (Pfizer) – out of stock, with resupply date to be confirmed
Colestid (colestipol) Orange (Pfizer) – out of stock until end of May 2021
This memo advises on management options for those products still out of stock.